Impact of Small Variations in the Delivered Dose of Rabbit Antithymocyte Induction Therapy in Kidney Transplantation With Early Corticosteroid Withdrawal
暂无分享,去创建一个
L. Ratner | B. Tanriover | M. Hardy | S. Mohan | D. Cohen | G. Dube | R. Crew | D. Tsapepas | P. Sandoval
[1] D. Brennan,et al. Thymoglobulin Induction Dosing Strategies in a Low-Risk Kidney Transplant Population: Three or Four Days? , 2010, Journal of transplantation.
[2] K. Flegal,et al. Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.
[3] R. Marcén,et al. Immunosuppressive Drugs in Kidney Transplantation , 2009, Drugs.
[4] C. Drachenberg,et al. Thymoglobulin Dose Optimization for Induction Therapy in High Risk Kidney Transplant Recipients , 2008, Transplantation.
[5] T. Mueller. Mechanisms of Action of Thymoglobulin , 2007 .
[6] A. Kirk. Induction Immunosuppression , 2006, Transplantation.
[7] W. Winkelmayer,et al. Comparison of two dosages of thymoglobulin used as a short‐course for induction in kidney transplantation , 2006, Transplant international : official journal of the European Society for Organ Transplantation.
[8] K. Flegal,et al. Prevalence of overweight and obesity in the United States, 1999-2004. , 2006, JAMA.
[9] Ron Shapiro,et al. Immunosuppression: evolution in practice and trends, 1993–2003 , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] K. Flegal,et al. Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.
[11] E. Woodle,et al. Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on cd3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients , 2002, Transplantation.
[12] T. Howard,et al. Short course induction immunosuppression with thymoglobulin for renal transplant recipients. , 2002, Transplantation.
[13] O. Toupance,et al. Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF‐containing Triple Therapy , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] J. Squifflet,et al. INDUCTION VERSUS NONINDUCTION IN RENAL TRANSPLANT RECIPIENTS WITH TACROLIMUS-BASED IMMUNOSUPPRESSION1 , 2001, Transplantation.
[15] M. Schnitzler,et al. A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. , 1999, Transplantation.
[16] G. Appel,et al. Use of ATG in treatment of steroid-resistant rejection. , 1980, Transplantation.